Otsuka Holdings Co., Ltd. (4578.T)

JPY 7697.0

(5.22%)

Long Term Debt Summary of Otsuka Holdings Co., Ltd.

  • Otsuka Holdings Co., Ltd.'s latest annual long term debt in 2023 was 69.2 Billion JPY , down -53.87% from previous year.
  • Otsuka Holdings Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was 68.67 Billion JPY , down -0.76% from previous quarter.
  • Otsuka Holdings Co., Ltd. reported annual long term debt of 150 Billion JPY in 2022, down -7.68% from previous year.
  • Otsuka Holdings Co., Ltd. reported annual long term debt of 162.48 Billion JPY in 2021, down -10.67% from previous year.
  • Otsuka Holdings Co., Ltd. reported quarterly long term debt of 87.47 Billion JPY for 2024 Q3, up 28.83% from previous quarter.
  • Otsuka Holdings Co., Ltd. reported quarterly long term debt of 68.67 Billion JPY for 2024 Q1, down -0.76% from previous quarter.

Annual Long Term Debt Chart of Otsuka Holdings Co., Ltd. (2023 - 2008)

Historical Annual Long Term Debt of Otsuka Holdings Co., Ltd. (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 69.2 Billion JPY -53.87%
2022 150 Billion JPY -7.68%
2021 162.48 Billion JPY -10.67%
2020 181.87 Billion JPY -3.51%
2019 188.48 Billion JPY 34.66%
2018 139.97 Billion JPY -20.9%
2017 176.96 Billion JPY -8.77%
2016 193.97 Billion JPY -19.02%
2015 239.52 Billion JPY 957.05%
2014 22.66 Billion JPY 13.45%
2013 19.97 Billion JPY 64.92%
2012 12.11 Billion JPY -61.83%
2011 31.73 Billion JPY -11.42%
2010 35.82 Billion JPY -48.81%
2009 69.98 Billion JPY -28.9%
2008 98.43 Billion JPY 0.0%

Peer Long Term Debt Comparison of Otsuka Holdings Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Kyowa Kirin Co., Ltd. 15.71 Billion JPY -340.316%
Astellas Pharma Inc. 447.73 Billion JPY 84.545%
Chugai Pharmaceutical Co., Ltd. 6.48 Billion JPY -967.901%
Ono Pharmaceutical Co., Ltd. 6.55 Billion JPY -956.166%
Santen Pharmaceutical Co., Ltd. 27.46 Billion JPY -151.975%
JCR Pharmaceuticals Co., Ltd. 14.35 Billion JPY -382.23%
Daiichi Sankyo Company, Limited 101.31 Billion JPY 31.697%
Perseus Proteomics Inc. - JPY -Infinity%